Gulsen Kama serves as Executive at Bionano Genomics, Inc., where they oversee executive responsibilities. Since joining the company, Gulsen Kama has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 3, 2024 involved receiving (via award) 16,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 3, 2024 | BNGO | $0 | Award | 16,000 | $N/A | Discretionary |
Gulsen Kama currently holds 16,000 shares of Bionano Genomics, Inc. (BNGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gulsen Kama has been a net neutral trader of BNGO stock. They have purchased $0 and sold $0 worth of shares.
Gulsen Kama's most recent insider trade was on Jun 3, 2024, when they sold 16,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted